- Home
- IFRX vs LFT Comparison
IFRX vs LFT Comparison
Compare IFRX & LFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IFRX | LFT |
|---|---|---|
| Founded | 2007 | 2012 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.6M | 69.1M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | IFRX | LFT |
|---|---|---|
| Price | $0.94 | $1.27 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 1 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 216.6K | 130.3K |
| Earning Date | 03-19-2026 | 03-16-2026 |
| Dividend Yield | N/A | ★ 12.50% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $124.75 |
| Revenue Next Year | $1,054.36 | N/A |
| P/E Ratio | ★ N/A | $13.49 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.71 | $1.26 |
| 52 Week High | $1.94 | $2.84 |
Technical Indicators
Market Signals| Indicator | IFRX | LFT |
|---|---|---|
| Relative Strength Index (RSI) | 49.25 | 40.95 |
| Support Level | $0.77 | $1.26 |
| Resistance Level | $1.16 | $1.41 |
| Average True Range (ATR) | 0.08 | 0.05 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 47.91 | 17.50 |
Price Performance
Historical ComparisonAbout IFRX InflaRx N.V.
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
About LFT Lument Finance Trust Inc.
Lument Finance Trust Inc operates as a real estate investment trust. The company is engaged in investment, financing, and management of a portfolio of commercial real estate debt investments. It invests in transitional floating-rate commercial real estate mortgage loans, mezzanine loans, preferred equity, commercial mortgage-backed securities, fixed-rate loans, construction loans, and other CRE debt instruments.